Measurement of Beta Cell Death in Individuals With Cystic Fibrosis
Sponsor: Cystic Fibrosis Foundation
A observational or N/A phase clinical study on Cystic Fibrosis-related Diabetes, this trial is completed. The trial is conducted by Cystic Fibrosis Foundation and has accumulated 14 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Oct 2024 — Present [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
-
Aug 2023 — Oct 2023 [monthly]
Completed
▶ Show 9 earlier versions
-
Sep 2022 — Aug 2023 [monthly]
Completed
-
Dec 2021 — Sep 2022 [monthly]
Completed
-
Sep 2021 — Dec 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2019 — Nov 2020 [monthly]
Recruiting
-
Apr 2019 — Aug 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Apr 2019 [monthly]
Not Yet Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cystic Fibrosis Foundation
- University of Nebraska
For direct contact, visit the study record on ClinicalTrials.gov .